Get access to Glenmark information and resources for stories in development.
Find recent and archived press releases.
November 16, 2018
Glenmark Pharmaceuticals Announces New Data Presentations on RyaltrisTM at the ACAAI Annual Scientific Meeting 2018
November 15, 2018
Glenmark Pharmaceuticals Announces Decision to Launch Phase 1 Trial in Solid Tumors for its CD38xCD3 Bispecific Antibody GBR 1342 Based on Human Translational Data
November 7, 2018
Glenmark Pharmaceuticals receives ANDA approval for Fluocinolone Acetonide Topical Oil, 0.01% (Scalp Oil)
October 30, 2018
Search Result :-Is an investigational new drug that has not been approved for commercial distribution in the United States.
US Media Contact
For media inquiries only, please contact An Phan, Corporate Communications.
For more information on Glenmark Pharmaceuticals Ltd., including Annual Reports, Analyst Presentations and Financial Results, please visit our Investor Relations.